Information  X 
Enter a valid email address

Kromek Group PLC (KMK)

  Print      Mail a friend

Monday 02 November, 2020

Kromek Group PLC

Result of AGM

RNS Number : 8521D
Kromek Group PLC
02 November 2020
 

2 November 2020

 

Kromek Group plc

("Kromek" or the "Group")

 

Result of AGM

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, announces that at its Annual General Meeting ("AGM"), held on 31 October 2020, all resolutions were duly passed.

 

Details of the proxy voting results, which should be read alongside the Notice of AGM, are below:

 

Resolution

Votes for*

Votes against

Votes withheld

Total proxy votes


No. of votes

% of votes cast**

No. of votes

% of votes cast**

No. of votes


1

74,653,527

92.69

5,890,397

7.31

5,564

80,549,488

2

80,437,403

99.93

54,458

0.07

57,627

80,549,488

3

70,926,554

88.07

9,607,093

11.93

15,841

80,549,488

4

74,653,648

92.70

5,879,446

7.30

16,394

80,549,488

5

74,498,108

92.56

5,986,420

7.44

64,960

80,549,488

6

80,432,526

99.92

64,195

0.08

52,767

80,549,488

7

80,114,214

99.79

166,688

0.21

268,586

80,549,488

8

77,685,709

96.67

2,679,634

3.33

184,145

80,549,488

9

74,455,013

92.55

5,992,097

7.45

102,378

80,549,488

10

80,479,482

99.96

32,458

0.04

37,548

80,549,488

* Includes discretionary votes

** Excludes withheld votes

 

 

For further information, please contact:

 

Kromek Group plc

 

Arnab Basu, CEO

Paul Farquhar, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Broker)

 

Max Hartley (NOMAD)

Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon (PR)

 

Harry Chathli

Claire Norbury

Alexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

 

About Kromek Group plc

 

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and

https://twitter.com/kromekgroup.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEAEFFEFSEFAA

a d v e r t i s e m e n t